UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ID1 Is a Functional Marker for Intestinal Stem and Progenitor Cells Required for Normal Response to Injury

Stem cell reports, 2014-11, Vol.3 (5), p.716-724

2014

Volltextzugriff (PDF)

Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) on the use of endoscopy simulators for training and assessing skill

Gastrointestinal endoscopy, 2012-09, Vol.76 (3), p.471-475

2012

Volltextzugriff (PDF)

Cerebral venous thrombosis in inflammatory bowel disease

Journal of digestive diseases, 2015-02, Vol.16 (2), p.104-108

2015

Volltextzugriff (PDF)

Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease

The American journal of gastroenterology, 2015-12, Vol.110 (12), p.1737-1738

2015

Volltextzugriff (PDF)

A Case-Based Approach to Constipation in Primary Care

The Medical clinics of North America, 2021-01, Vol.105 (1), p.55-73

2021

Volltextzugriff (PDF)

Demographics and Outcomes of Patients Cared for in an Integrated Academic Inflammatory Bowel Disease Center: 593

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S340-S340

2018

Volltextzugriff (PDF)

Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials

Digestive diseases and sciences, 2021-05, Vol.66 (5), p.1631-1638

2021

Volltextzugriff (PDF)

Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease

Digestive diseases and sciences, 2018-09, Vol.63 (9), p.2439-2444

2018

Volltextzugriff (PDF)

S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity

Journal of lipid research, 2013-03, Vol.54 (3), p.843-851

2013

Volltextzugriff (PDF)

Cirrhotic Patients Have Worse Bowel Preparation at Screening Colonoscopy than Chronic Liver Disease Patients without Cirrhosis

Journal of clinical and experimental hepatology, 2016-12, Vol.6 (4), p.297-302

2016

Volltextzugriff (PDF)

Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease

Digestive diseases and sciences, 2016-01, Vol.61 (1), p.215-220

2016

Volltextzugriff (PDF)

The impact of COVID-19 monoclonal antibodies on clinical outcomes: A retrospective cohort study

American journal of health-system pharmacy, 2022-12, Vol.79 (24), p.2222-2229

2022

Volltextzugriff (PDF)

Effect of a Team-Based Approach to Improve Enteral Access Decision-Making: 1060

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S607-S607

2018

Volltextzugriff (PDF)

A Clinical and Radiographic Model to Guide Medical versus Surgical Management for Acute Small Bowel Obstruction in Crohnʼs Disease: 613

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S350-S351

2018

Volltextzugriff (PDF)

Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies

Inflammatory bowel diseases, 2016-08, Vol.22 (8), p.1881-1886

2016

Volltextzugriff (PDF)

Sa1119 Current Access to Vedolizumab (VDZ): Who Requires Prior Authorizations and How It Delays Care

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S246-S246

2016

Volltextzugriff (PDF)

Patients Cared for in an Integrated Academic IBD Practice have Lower Readmission Rates: A Key Quality Indicator

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S218-S218

2017

Volltextzugriff (PDF)

Adverse Events with use of Ustekinumab: A Systematic Review and Meta-Analysis

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S578-S579

2017

Volltextzugriff (PDF)

The COVID-19 Army: Experiences From the Deployment of Non-Hospitalist Physician Volunteers During the COVID-19 Pandemic

Disaster medicine and public health preparedness, 2022-12, Vol.16 (6), p.1-2309

2022

Volltextzugriff (PDF)

Mo1907 Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S813-S813

2016

Volltextzugriff (PDF)

Id1 Expression in Endothelial Cells of the Colon Is Required for Normal Response to Injury

The American journal of pathology, 2015-11, Vol.185 (11), p.2983-2993

2015

Volltextzugriff (PDF)

Individuals at High-Risk for an Acute Infliximab Infusion Reaction: What Factors are Predictive of a Reaction and are Premedications Effective at Reducing the Risk?

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S792-S793

2017

Volltextzugriff (PDF)

Predictors of Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S584-S585

2017

Volltextzugriff (PDF)

Comparisons of Premedication Strategies for Preventing Infliximab Related Infusion Reactions in Patients with Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S109-S109

2017

Volltextzugriff (PDF)

Mo1273 Influence of Cirrhosis on Quality of Bowel Preparation and Polyp Detection Rate During Screening Colonoscopy

Gastrointestinal endoscopy, 2012-04, Vol.75 (4), p.AB372-AB372

2012

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(99)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(124)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ID1 Is a Functional Marker for Intestinal Stem and Progenitor Cells Required for Normal Response to Injury

Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) on the use of endoscopy simulators for training and assessing skill

Cerebral venous thrombosis in inflammatory bowel disease

Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease

A Case-Based Approach to Constipation in Primary Care

Demographics and Outcomes of Patients Cared for in an Integrated Academic Inflammatory Bowel Disease Center: 593

Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials

Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease

S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity

Cirrhotic Patients Have Worse Bowel Preparation at Screening Colonoscopy than Chronic Liver Disease Patients without Cirrhosis

Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease

The impact of COVID-19 monoclonal antibodies on clinical outcomes: A retrospective cohort study

Effect of a Team-Based Approach to Improve Enteral Access Decision-Making: 1060

A Clinical and Radiographic Model to Guide Medical versus Surgical Management for Acute Small Bowel Obstruction in Crohnʼs Disease: 613

Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies

Sa1119 Current Access to Vedolizumab (VDZ): Who Requires Prior Authorizations and How It Delays Care

Patients Cared for in an Integrated Academic IBD Practice have Lower Readmission Rates: A Key Quality Indicator

Adverse Events with use of Ustekinumab: A Systematic Review and Meta-Analysis

The COVID-19 Army: Experiences From the Deployment of Non-Hospitalist Physician Volunteers During the COVID-19 Pandemic

Mo1907 Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease

Id1 Expression in Endothelial Cells of the Colon Is Required for Normal Response to Injury

Individuals at High-Risk for an Acute Infliximab Infusion Reaction: What Factors are Predictive of a Reaction and are Premedications Effective at Reducing the Risk?

Predictors of Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease

Comparisons of Premedication Strategies for Preventing Infliximab Related Infusion Reactions in Patients with Inflammatory Bowel Disease

Mo1273 Influence of Cirrhosis on Quality of Bowel Preparation and Polyp Detection Rate During Screening Colonoscopy

Suchergebnisse filtern